INTELLIA THERAPEUTICS, INC. Operating Lease Liability
INTELLIA THERAPEUTICS, INC. (NTLA) had Operating Lease Liability of $73.41 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability $73.41M.
- 2026-03-31: Operating Lease, Liability $80.49M.
- 2025-12-31: Operating Lease, Liability $93.33M.
- 2025-09-30: Operating Lease, Liability $97.97M.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $73.41M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $80.49M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $93.33M 10-K · filed 2026-02-26 |
| 2025-09-30 | $97.97M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $102.59M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $119.25M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $210.20M 10-K · filed 2025-02-27 |
| 2023-12-31 | $115.35M 10-K · filed 2024-02-22 |
| 2022-12-31 | $130.70M 10-K · filed 2023-02-23 |
| 2021-12-31 | $74.02M 10-K · filed 2022-02-24 |
| 2020-12-31 | $39.30M 10-K · filed 2021-02-26 |
| 2019-12-31 | $18.38M 10-K · filed 2020-02-27 |
| 2019-09-30 | $19.65M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $19.67M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $19.51M 10-Q · filed 2019-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |